comparemela.com

Latest Breaking News On - Quarter for supernus pharmaceuticals - Page 1 : comparemela.com

Scout Investments Inc Lowers Stake in Supernus Pharmaceuticals, Inc (NASDAQ:SUPN)

Scout Investments Inc. lowered its stake in shares of Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN – Free Report) by 1.5% in the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 282,400 shares of the specialty pharmaceutical company’s stock after selling 4,429 shares during the period. Scout Investments Inc. owned approximately […]

Congress Wealth Management LLC DE Cuts Stock Holdings in Supernus Pharmaceuticals, Inc (NASDAQ:SUPN)

Congress Wealth Management LLC DE trimmed its holdings in shares of Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN – Free Report) by 18.9% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 129,051 shares of the specialty pharmaceutical company’s stock after selling 30,095 shares during the quarter. Congress […]

Mach 1 Financial Group LLC Buys Shares of 14,554 Supernus Pharmaceuticals, Inc (NASDAQ:SUPN)

Mach 1 Financial Group LLC purchased a new position in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN – Free Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund purchased 14,554 shares of the specialty pharmaceutical company’s stock, valued at approximately $421,000. A number of other institutional […]

Supernus Pharmaceuticals, Inc (NASDAQ:SUPN) VP Sells $511,677 21 in Stock

Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN – Get Free Report) VP Padmanabh P. Bhatt sold 14,491 shares of the company’s stock in a transaction dated Thursday, March 21st. The stock was sold at an average price of $35.31, for a total value of $511,677.21. Following the transaction, the vice president now directly owns 8,570 shares of the […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.